| Identification | Back Directory | [Name]
Ragifilimab | [CAS]
2207590-51-8 | [Synonyms]
Ragifilimab
Ragifilimab (anti-TNFRSF18)
INCAGN-01876|||INCAGN-1876|||CM-701
Research Grade Ragifilimab (DHJ89801) |
| Hazard Information | Back Directory | [Uses]
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research[1]. | [IC 50]
GITR | [References]
[1] Hernandez-Guerrero T, et al: Not Ready for Prime Time. Clin Cancer Res. 2022 Sep 15;28(18):3905-3907. DOI:10.1158/1078-0432.CCR-22-1489 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|